 | • レポートコード：GIR-105X08420 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、単純ヘルペスウイルス（HSV）ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。単純ヘルペスウイルス（HSV）ワクチンの種類別市場規模（GEN-003、VCL-HB01、HSV529、その他）、用途別市場規模（HSV-1（口唇ヘルペス）、HSV-2（性器ヘルペス））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・単純ヘルペスウイルス（HSV）ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、GlaxoSmithKline、Genocea Biosciences、Vical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：GEN-003、VCL-HB01、HSV529、その他 ・用途別分析2016年-2026年：HSV-1（口唇ヘルペス）、HSV-2（性器ヘルペス） ・単純ヘルペスウイルス（HSV）ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・単純ヘルペスウイルス（HSV）ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・単純ヘルペスウイルス（HSV）ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・単純ヘルペスウイルス（HSV）ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・単純ヘルペスウイルス（HSV）ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Herpes Simplex Virus (HSV) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Herpes Simplex Virus (HSV) Vaccines size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Herpes Simplex Virus (HSV) Vaccines market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Herpes Simplex Virus (HSV) Vaccines market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
GEN-003
VCL-HB01
HSV529
Others
Market segment by Application can be divided into
HSV-1 (Oral Herpes)
HSV-2 (Genital Herpes)
The key market players for global Herpes Simplex Virus (HSV) Vaccines market are listed below:
Sanofi
GlaxoSmithKline
Genocea Biosciences
Vical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Herpes Simplex Virus (HSV) Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 GEN-003
1.2.3 VCL-HB01
1.2.4 HSV529
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 HSV-1 (Oral Herpes)
1.3.3 HSV-2 (Genital Herpes)
1.4 Global Herpes Simplex Virus (HSV) Vaccines Market Size & Forecast
1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Value (2016-2026))
1.4.2 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume (2016-2026)
1.4.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2016-2026) & (USD/Unit)
1.5 Global Herpes Simplex Virus (HSV) Vaccines Production Capacity Analysis
1.5.1 Global Herpes Simplex Virus (HSV) Vaccines Total Production Capacity (2016-2026)
1.5.2 Global Herpes Simplex Virus (HSV) Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Herpes Simplex Virus (HSV) Vaccines Market Drivers
1.6.2 Herpes Simplex Virus (HSV) Vaccines Market Restraints
1.6.3 Herpes Simplex Virus (HSV) Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Product and Services
2.1.4 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business
2.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product and Services
2.2.4 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Genocea Biosciences
2.3.1 Genocea Biosciences Details
2.3.2 Genocea Biosciences Major Business
2.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product and Services
2.3.4 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Vical
2.4.1 Vical Details
2.4.2 Vical Major Business
2.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Product and Services
2.4.4 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturer
3.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Herpes Simplex Virus (HSV) Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Herpes Simplex Virus (HSV) Vaccines Manufacturer Market Share
3.4.2 Top 6 Herpes Simplex Virus (HSV) Vaccines Manufacturer Market Share
3.5 Global Herpes Simplex Virus (HSV) Vaccines Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Herpes Simplex Virus (HSV) Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Herpes Simplex Virus (HSV) Vaccines Market Size by Region
4.1.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Region (2016-2026)
4.1.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2016-2026)
4.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026)
4.3 Europe Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026)
4.4 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026)
4.5 South America Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026)
4.6 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Type (2016-2026)
5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2016-2026)
5.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Application (2016-2026)
6.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2016-2026)
6.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2026)
7.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2026)
7.3 North America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
7.3.1 North America Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Country (2016-2026)
7.3.2 North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2026)
8.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2026)
8.3 Europe Herpes Simplex Virus (HSV) Vaccines Market Size by Country
8.3.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Country (2016-2026)
8.3.2 Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2026)
9.2 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2026)
9.3 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Market Size by Region
9.3.1 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2026)
10.2 South America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2026)
10.3 South America Herpes Simplex Virus (HSV) Vaccines Market Size by Country
10.3.1 South America Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Country (2016-2026)
10.3.2 South America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2026)
11.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2026)
11.3 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Market Size by Country
11.3.1 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Herpes Simplex Virus (HSV) Vaccines Typical Distributors
12.3 Herpes Simplex Virus (HSV) Vaccines Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type, (USD Million), 2021-2026
Table 2. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Herpes Simplex Virus (HSV) Vaccines Product and Services
Table 6. Sanofi Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 8. GlaxoSmithKline Major Business
Table 9. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Product and Services
Table 10. GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Genocea Biosciences Basic Information, Manufacturing Base and Competitors
Table 12. Genocea Biosciences Major Business
Table 13. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Product and Services
Table 14. Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Vical Basic Information, Manufacturing Base and Competitors
Table 16. Vical Major Business
Table 17. Vical Herpes Simplex Virus (HSV) Vaccines Product and Services
Table 18. Vical Herpes Simplex Virus (HSV) Vaccines Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Herpes Simplex Virus (HSV) Vaccines Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Herpes Simplex Virus (HSV) Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Herpes Simplex Virus (HSV) Vaccines Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Herpes Simplex Virus (HSV) Vaccines Production Site of Key Manufacturer
Table 24. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2016-2021e) & (K Units)
Table 25. Global Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2026) & (K Units)
Table 26. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 29. Global Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (K Units)
Table 30. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2016-2021e) & (USD/Unit)
Table 33. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2021-2026) & (USD/Unit)
Table 34. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 35. Global Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (K Units)
Table 36. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Herpes Simplex Virus (HSV) Vaccines Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2016-2021e) & (USD/Unit)
Table 39. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2021-2026) & (USD/Unit)
Table 40. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2016-2021e) & (K Units)
Table 41. North America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (K Units)
Table 42. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 45. North America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (K Units)
Table 46. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 47. North America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (K Units)
Table 48. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2016-2021e) & (K Units)
Table 49. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (K Units)
Table 50. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 53. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (K Units)
Table 54. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 55. Europe Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (K Units)
Table 56. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2016-2021e) & (K Units)
Table 57. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region (2021-2026) & (K Units)
Table 58. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 61. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (K Units)
Table 62. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 63. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (K Units)
Table 64. South America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2016-2021e) & (K Units)
Table 65. South America Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (K Units)
Table 66. South America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 69. South America Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (K Units)
Table 70. South America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 71. South America Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2016-2021e) & (K Units)
Table 73. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country (2021-2026) & (K Units)
Table 74. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2016-2021e) & (K Units)
Table 77. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Type (2021-2026) & (K Units)
Table 78. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2016-2021e) & (K Units)
Table 79. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales by Application (2021-2026) & (K Units)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Herpes Simplex Virus (HSV) Vaccines Typical Distributors
Table 83. Herpes Simplex Virus (HSV) Vaccines Typical Customers
List of Figures
Figure 1. Herpes Simplex Virus (HSV) Vaccines Picture
Figure 2. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type in 2020
Figure 3. GEN-003
Figure 4. VCL-HB01
Figure 5. HSV529
Figure 6. Others
Figure 7. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application in 2020
Figure 8. HSV-1 (Oral Herpes)
Figure 9. HSV-2 (Genital Herpes)
Figure 10. Global Herpes Simplex Virus (HSV) Vaccines Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Herpes Simplex Virus (HSV) Vaccines Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Herpes Simplex Virus (HSV) Vaccines Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Herpes Simplex Virus (HSV) Vaccines Sales (2016-2026) & (K Units)
Figure 32. Global Herpes Simplex Virus (HSV) Vaccines Production Capacity (2016-2026) & (K Units)
Figure 33. Global Herpes Simplex Virus (HSV) Vaccines Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Herpes Simplex Virus (HSV) Vaccines Market Drivers
Figure 35. Herpes Simplex Virus (HSV) Vaccines Market Restraints
Figure 36. Herpes Simplex Virus (HSV) Vaccines Market Trends
Figure 37. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturer in 2020
Figure 38. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Manufacturer in 2020
Figure 39. Herpes Simplex Virus (HSV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Herpes Simplex Virus (HSV) Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Herpes Simplex Virus (HSV) Vaccines Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2016-2026)
Figure 43. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2016-2026)
Figure 44. North America Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026) & (USD Million)
Figure 45. Europe Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026) & (USD Million)
Figure 47. South America Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue (2016-2026) & (USD Million)
Figure 49. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2026)
Figure 50. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2016-2026)
Figure 51. Global Herpes Simplex Virus (HSV) Vaccines Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2026)
Figure 53. Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2016-2026)
Figure 54. Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2016-2026)
Figure 56. North America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2016-2026)
Figure 57. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2026)
Figure 58. North America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2026)
Figure 59. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2016-2026)
Figure 60. Europe Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2016-2026)
Figure 61. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2026)
Figure 62. Europe Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2026)
Figure 67. South America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2016-2026)
Figure 68. South America Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2016-2026)
Figure 69. South America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2026)
Figure 70. South America Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
単純ヘルペスウイルス治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. It is also used to treat outbreaks of genital herpes. In people with frequent outbrea…- ヘルペス治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially. With respect to sexually …
- C型肝炎ウイルスと治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma Scope of the Report: This report studies the Hepatitis C Virus And Therapeutics market status and…
- 腫瘍崩壊性ウイルス免疫療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus …
- ヒト免疫不全ウイルス（HIV）-1治療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…